Globus Medical PE Ratio 2010-2024 | GMED

Current and historical p/e ratio for Globus Medical (GMED) from 2010 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Globus Medical PE ratio as of May 23, 2024 is 26.65.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Globus Medical PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2024-05-23 65.39 102.17
2024-03-31 53.64 $0.64 83.81
2023-12-31 53.29 $1.17 45.55
2023-09-30 49.65 $1.55 32.03
2023-06-30 59.54 $2.01 29.62
2023-03-31 56.64 $1.97 28.75
2022-12-31 74.27 $1.86 39.93
2022-09-30 59.57 $1.51 39.45
2022-06-30 56.14 $1.49 37.68
2022-03-31 73.78 $1.36 54.25
2021-12-31 72.20 $1.43 50.49
2021-09-30 76.62 $1.81 42.33
2021-06-30 77.53 $1.80 43.07
2021-03-31 61.67 $1.19 51.82
2020-12-31 65.22 $1.00 65.22
2020-09-30 49.52 $0.92 53.83
2020-06-30 47.71 $0.86 55.48
2020-03-31 42.53 $1.45 29.33
2019-12-31 58.88 $1.56 37.74
2019-09-30 51.12 $1.47 34.78
2019-06-30 42.30 $1.53 27.65
2018-12-31 43.28 $1.54 28.10
2018-09-30 56.76 $1.43 39.69
2018-06-30 50.46 $1.41 35.79
2018-03-31 49.82 $1.23 40.50
2017-12-31 41.10 $1.13 36.37
2019-03-31 49.41 $1.18 41.87
2017-09-30 29.72 $1.10 27.02
2017-06-30 33.15 $1.11 29.86
2017-03-31 29.62 $1.09 27.17
2016-12-31 24.81 $1.08 22.97
2016-09-30 22.57 $1.22 18.50
2016-06-30 23.83 $1.23 19.37
2016-03-31 23.75 $1.21 19.63
2015-12-31 27.82 $1.18 23.58
2015-09-30 20.66 $1.08 19.13
2015-06-30 25.67 $1.04 24.68
2015-03-31 25.24 $1.01 24.99
2014-12-31 23.77 $0.97 24.51
2014-09-30 19.67 $0.90 21.86
2014-06-30 23.92 $0.88 27.18
2014-03-31 26.59 $0.74 35.93
2013-12-31 20.18 $0.73 27.64
2013-09-30 17.46 $0.73 23.92
2013-06-30 16.86 $0.69 24.43
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $9.090B $1.568B
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $225.518B 27.33
Intuitive Surgical (ISRG) United States $142.199B 85.66
Edwards Lifesciences (EW) United States $54.361B 35.38
DexCom (DXCM) United States $51.910B 78.63
Alcon (ALC) Switzerland $44.749B 32.07
IDEXX Laboratories (IDXX) United States $42.775B 50.14
IQVIA Holdings (IQV) United States $41.183B 23.89
STERIS (STE) Ireland $22.787B 26.63
Waters (WAT) United States $20.691B 30.41
SONOVA HOLDING (SONVY) Switzerland $18.917B 0.00
Hologic (HOLX) United States $17.459B 19.53
ShockWave Medical (SWAV) United States $12.540B 78.04
Fresenius Medical Care AG KGaA (FMS) Germany $12.235B 14.28
Sysmex ADR (SSMXY) Japan $10.844B 34.01
Teleflex (TFX) United States $10.037B 15.62
Penumbra (PEN) United States $7.713B 87.65
Masimo (MASI) United States $6.721B 38.72
Glaukos (GKOS) United States $5.426B 0.00
TransMedics (TMDX) United States $4.511B 428.03
Integer Holdings (ITGR) United States $4.073B 24.61
PROCEPT BioRobotics (PRCT) United States $3.449B 0.00
Tandem Diabetes Care (TNDM) United States $3.319B 0.00
LivaNova (LIVN) United Kingdom $3.280B 19.48
Elekta AB (EKTAY) Sweden $3.078B 21.12
Inari Medical (NARI) United States $2.771B 0.00
Nihon Kohden (NHNKY) Japan $2.493B 21.08
RxSight (RXST) United States $2.285B 0.00
Integra LifeSciences Holdings (IART) United States $2.216B 9.66
Veracyte (VCYT) United States $1.653B 0.00
Alphatec Holdings (ATEC) United States $1.505B 0.00
Artivion (AORT) United States $0.991B 95.04
AVANOS MEDICAL, INC (AVNS) United States $0.935B 18.18
OPKO Health (OPK) United States $0.920B 0.00
Silk Road Medical (SILK) United States $0.878B 0.00
OrthoPediatrics (KIDS) United States $0.790B 0.00
Pulse Biosciences (PLSE) United States $0.659B 0.00
Paragon 28 (FNA) United States $0.653B 0.00
Mesa Laboratories (MLAB) United States $0.617B 20.94
SiBone (SIBN) United States $0.578B 0.00
IRadimed (IRMD) United States $0.551B 30.88
ORTHOFIX MEDICAL INC (OFIX) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.504B 0.00
Nevro (NVRO) United States $0.360B 0.00
Treace Medical Concepts (TMCI) United States $0.331B 0.00
Tactile Systems Technology (TCMD) United States $0.307B 10.50
AxoGen (AXGN) United States $0.271B 0.00
Sight Sciences (SGHT) United States $0.261B 0.00
AngioDynamics (ANGO) United States $0.253B 0.00
908 Devices (MASS) United States $0.233B 0.00
NeuroPace (NPCE) United States $0.228B 0.00
EDAP TMS S.A (EDAP) France $0.223B 0.00
Delcath Systems (DCTH) United States $0.218B 0.00
Inogen (INGN) United States $0.204B 0.00
Atossa Genetics (ATOS) United States $0.192B 0.00
Alpha Tau Medical (DRTS) Israel $0.189B 0.00
CVRx (CVRX) United States $0.184B 0.00
ClearPoint Neuro (CLPT) United States $0.166B 0.00
Semler Scientific (SMLR) United States $0.165B 8.37
Accuray (ARAY) United States $0.152B 0.00
Yubo Biotech (YBGJ) China $0.110B 0.00
KORU Medical Systems (KRMD) United States $0.102B 0.00
Spectral Diagnostics (EDTXF) Canada $0.101B 0.00
Sensus Healthcare (SRTS) United States $0.096B 20.10
Neuronetics (STIM) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.066B 0.00
Hyperfine (HYPR) United States $0.065B 0.00
Monogram Orthopaedics (MGRM) United States $0.063B 0.00
Vicarious Surgical (RBOT) United States $0.062B 0.00
InspireMD (NSPR) Israel $0.061B 0.00
Envoy Medical (COCH) United States $0.059B 0.00
SEP Acquisition (SEPA) United States $0.052B 0.00
DarioHealth (DRIO) United States $0.052B 0.00
Autonomix Medical (AMIX) United States $0.048B 0.00
Lucid Diagnostics (LUCD) United States $0.048B 0.00
LENSAR (LNSR) United States $0.047B 0.00
ReWalk Robotics (LFWD) Israel $0.043B 0.00
Precision Optics (POCI) United States $0.040B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Pixie Dust Technologies (PXDT) Japan $0.035B 0.00
Aspira Women's Health (AWH) United States $0.031B 0.00
T2 Biosystems (TTOO) United States $0.031B 0.00
Spectral AI (MDAI) United States $0.029B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.028B 0.00
Ekso Bionics Holdings (EKSO) United States $0.025B 0.00
Accelerate Diagnostics (AXDX) United States $0.023B 0.00
Biosig Technologies (BSGM) United States $0.020B 0.00
QT Imaging Holdings (QTI) United States $0.019B 0.00
PAVmed (PAVM) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
NexGel (NXGL) United States $0.015B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.011B 0.00
Avinger (AVGR) United States $0.005B 0.00
Nuwellis (NUWE) United States $0.004B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Dynatronics (DYNT) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00